RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
124 hedge funds and large institutions have $900M invested in Ra Pharmaceuticals, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
124
Holding in Top 10
5
Calls
–
Puts
$2K
Top Buyers
| 1 | +$15.7M | |
| 2 | +$11.8M | |
| 3 | +$7.23M | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$7.05M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$6.72M |
Top Sellers
| 1 | -$28.4M | |
| 2 | -$16.8M | |
| 3 | -$8.53M | |
| 4 |
Man Group
London,
United Kingdom
|
-$3.07M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.55M |